Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Targeting NuRD for derepression of fetal hemoglobin in hemoglobinopathies

Aug. 22, 2019

Pharmadiall presents new coagulation factor Xa inhibitors

Aug. 14, 2019

Mitsubishi Tanabe Pharma announces initiation of development of gene therapy for hemophilia B

Aug. 6, 2019

Pivotal phase III RESET study of rivipansel does not meet primary nor key secondary endpoints

Aug. 5, 2019

Momenta Pharmaceuticals launches phase II/III study of nipocalimab in wAIHA

Aug. 2, 2019

FDA approves Accrufer for iron deficiency in adults

July 29, 2019

First-generation PI3KC2alpha inhibitors as promising antithrombotic agents

July 23, 2019

Discovery and preclinical identification of novel NOX1-selective inhibitor, 2APT-PD06

July 23, 2019

Achillion presents promising data from phase I MAD study of ACH-5228

July 23, 2019

Mimicking bone marrow keeps cultured blood stem cells quiescent

July 18, 2019

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...